In these cancers, overexpression of PTENP1 led to a decrease in cell proliferation, suppression of cell migration and invasion, and induction of apoptosis through downregulation of the AKT and MAPK signalling pathways as well as downregulation of critical cell cycle proteins cyclin A2 and CDK2, in breast cancer [157]. The gene discussed is AKT1; the disease is cancer.